药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Etretinate
Semuloparin
The risk or severity of bleeding and bruising can be increased when Semuloparin is combined with Ursodeoxycholic acid.
Etretinate
Sulodexide
The risk or severity of bleeding and bruising can be increased when Sulodexide is combined with Ursodeoxycholic acid.
Etretinate
Rivaroxaban
The risk or severity of bleeding and bruising can be increased when Rivaroxaban is combined with Ursodeoxycholic acid.
Etretinate
Fibrinolysin
The risk or severity of bleeding and bruising can be increased when Fibrinolysin is combined with Ursodeoxycholic acid.
Etretinate
Ancrod
The risk or severity of bleeding and bruising can be increased when Ancrod is combined with Ursodeoxycholic acid.
Etretinate
Desmoteplase
The risk or severity of bleeding and bruising can be increased when Desmoteplase is combined with Ursodeoxycholic acid.
Etretinate
Ximelagatran
The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Ursodeoxycholic acid.
Etretinate
Coumarin
The risk or severity of bleeding and bruising can be increased when Coumarin is combined with Ursodeoxycholic acid.
Etretinate
4-hydroxycoumarin
The risk or severity of bleeding and bruising can be increased when 4-hydroxycoumarin is combined with Ursodeoxycholic acid.
Etretinate
Enoxaparin
The risk or severity of bleeding and bruising can be increased when Enoxaparin is combined with Ursodeoxycholic acid.
Etretinate
Heparin
The risk or severity of bleeding and bruising can be increased when Heparin is combined with Ursodeoxycholic acid.
Etretinate
Phenprocoumon
The risk or severity of bleeding and bruising can be increased when Phenprocoumon is combined with Ursodeoxycholic acid.
Cyclobenzaprine
Filgotinib
The serum concentration of Liotrix can be increased when it is combined with Filgotinib.
Cyclobenzaprine
Satralizumab
The serum concentration of Liotrix can be decreased when it is combined with Satralizumab.
Cyclobenzaprine
Abametapir
The serum concentration of Liotrix can be increased when it is combined with Abametapir.
Cyclobenzaprine
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Liotrix.
Cyclobenzaprine
Imipramine oxide
The risk or severity of Cardiac Arrhythmia can be increased when Liotrix is combined with Imipramine oxide.
Cyclobenzaprine
Iprindole
The risk or severity of Cardiac Arrhythmia can be increased when Liotrix is combined with Iprindole.
Cyclobenzaprine
Lofepramine
The risk or severity of Cardiac Arrhythmia can be increased when Liotrix is combined with Lofepramine.
Cyclobenzaprine
Melitracen
The risk or severity of Cardiac Arrhythmia can be increased when Liotrix is combined with Melitracen.